149 related articles for article (PubMed ID: 30537383)
21. MIBG in neuroblastoma diagnosis and treatment.
Olecki E; Grant CN
Semin Pediatr Surg; 2019 Dec; 28(6):150859. PubMed ID: 31931960
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and Clinical Correlations of Somatostatin Receptor-2 (SSTR2) Expression in Neuroblastoma.
Alexander N; Marrano P; Thorner P; Naranjo A; Van Ryn C; Martinez D; Batra V; Zhang L; Irwin MS; Baruchel S
J Pediatr Hematol Oncol; 2019 Apr; 41(3):222-227. PubMed ID: 30334904
[TBL] [Abstract][Full Text] [Related]
23. Radiation quality-dependent bystander effects elicited by targeted radionuclides.
Boyd M; Sorensen A; McCluskey AG; Mairs RJ
J Pharm Pharmacol; 2008 Aug; 60(8):951-8. PubMed ID: 18644188
[TBL] [Abstract][Full Text] [Related]
24. The effect of cisplatin pretreatment on the accumulation of MIBG by neuroblastoma cells in vitro.
Armour A; Cunningham SH; Gaze MN; Wheldon TE; Mairs RJ
Br J Cancer; 1997; 75(4):470-6. PubMed ID: 9052395
[TBL] [Abstract][Full Text] [Related]
25. Gene manipulation to enhance MIBG-targeted radionuclide therapy.
Mairs RJ; Fullerton NE; Cosimo E; Boyd M
Nucl Med Biol; 2005 Oct; 32(7):749-53. PubMed ID: 16243651
[TBL] [Abstract][Full Text] [Related]
26. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of monoamine transporters in neuroblastoma cell lines: correlations to meta-iodobenzylguanidine (MIBG) uptake and tyrosine hydroxylase gene expression.
Lode HN; Bruchelt G; Seitz G; Gebhardt S; Gekeler V; Niethammer D; Beck J
Eur J Cancer; 1995; 31A(4):586-90. PubMed ID: 7576974
[TBL] [Abstract][Full Text] [Related]
27. Organic cation transporter 3 mediates the non-norepinephrine transporter driven uptake of meta-[
Ohshima Y; Sasaki I; Watanabe S; Sakashita T; Higashi T; Ishioka NS
Nucl Med Biol; 2022; 112-113():44-51. PubMed ID: 35802985
[TBL] [Abstract][Full Text] [Related]
28. Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter-Expressing Tumors.
Yamaguchi A; Hanaoka H; Higuchi T; Tsushima Y
J Nucl Med; 2018 May; 59(5):815-821. PubMed ID: 29217738
[No Abstract] [Full Text] [Related]
29. Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group.
Temple W; Mendelsohn L; Kim GE; Nekritz E; Gustafson WC; Lin L; Giacomini K; Naranjo A; Van Ryn C; Yanik GA; Kreissman SG; Hogarty M; Matthay KK; DuBois SG
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):474-481. PubMed ID: 26338179
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and biological evaluation of novel bifunctional thyrointegrin antagonists for neuroblastoma.
Karakus OO; Godugu K; Fujioka K; Mousa SA
Bioorg Med Chem; 2021 Jul; 42():116250. PubMed ID: 34118788
[TBL] [Abstract][Full Text] [Related]
31. Experimental treatment of neuroblastoma using [131I]meta-iodobenzylguanidine and topotecan in combination.
McCluskey AG; Boyd M; Pimlott SL; Babich JW; Gaze MN; Mairs RJ
Br J Radiol; 2008 Oct; 81 Spec No 1():S28-35. PubMed ID: 18819996
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of poly(ADP-Ribose) polymerase enhances the toxicity of 131I-metaiodobenzylguanidine/topotecan combination therapy to cells and xenografts that express the noradrenaline transporter.
McCluskey AG; Mairs RJ; Tesson M; Pimlott SL; Babich JW; Gaze MN; Champion S; Boyd M
J Nucl Med; 2012 Jul; 53(7):1146-54. PubMed ID: 22689924
[TBL] [Abstract][Full Text] [Related]
33. Spatial Inhomogeneity of Cardiac Norepinephrine Transport Protein and Meta-[
Kusmic C; Giorgetti A; Barsanti C; Burchielli S; Petroni D; Kusch A; Genovesi D; Menichetti L; Marzullo P
Mol Imaging Biol; 2019 Jun; 21(3):482-490. PubMed ID: 30187232
[TBL] [Abstract][Full Text] [Related]
34. A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients.
Hoefnagel CA; Rutgers M; Buitenhuis CK; Smets LA; de Kraker J; Meli M; Carrel F; Amstutz H; Schubiger PA; Novak-Hofer I
Eur J Nucl Med; 2001 Mar; 28(3):359-68. PubMed ID: 11315605
[TBL] [Abstract][Full Text] [Related]
35. Norepinephrine Transporter as a Target for Imaging and Therapy.
Pandit-Taskar N; Modak S
J Nucl Med; 2017 Sep; 58(Suppl 2):39S-53S. PubMed ID: 28864611
[TBL] [Abstract][Full Text] [Related]
36. Initial Evaluation of AF78: a Rationally Designed Fluorine-18-Labelled PET Radiotracer Targeting Norepinephrine Transporter.
Chen X; Fritz A; Werner RA; Nose N; Yagi Y; Kimura H; Rowe SP; Koshino K; Decker M; Higuchi T
Mol Imaging Biol; 2020 Jun; 22(3):602-611. PubMed ID: 31332629
[TBL] [Abstract][Full Text] [Related]
37. Targeting of meta-iodobenzylguanidine to SK-N-SH human neuroblastoma xenografts: tissue distribution, metabolism and therapeutic efficacy.
Rutgers M; Buitenhuis CK; Hoefnagel CA; Voƻte PA; Smets LA
Int J Cancer; 2000 Aug; 87(3):412-22. PubMed ID: 10897048
[TBL] [Abstract][Full Text] [Related]
38. Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake.
Blom T; Meinsma R; Rutgers M; Buitenhuis C; Dekken-Van den Burg M; van Kuilenburg ABP; Tytgat GAM
EJNMMI Res; 2020 Jul; 10(1):78. PubMed ID: 32642907
[TBL] [Abstract][Full Text] [Related]
39. Cotransfecting norepinephrine transporter and vesicular monoamine transporter 2 genes for increased retention of metaiodobenzylguanidine labeled with iodine 131 in malignant hepatocarcinoma cells.
Zhao Y; Zhong X; Ou X; Cai H; Wu X; Huang R
Front Med; 2017 Mar; 11(1):120-128. PubMed ID: 28213878
[TBL] [Abstract][Full Text] [Related]
40. Meta-iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK-N-BE(2C).
Lashford LS; Hancock JP; Kemshead JT
Int J Cancer; 1991 Jan; 47(1):105-9. PubMed ID: 1985865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]